Marker Therapeutics, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-11.0M | $-2.5M | $-34.1M | $-30.9M | $-5.5M | $-5.9M | $-2.0M | $-3.5M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $2.7M | $1.6M | $1.7M | $1.4M | $132.1K | $2.4M | $1.3M | $2.1M |
| Net Cash from Operating Activities | $-8.4M | $-6.5M | $-4.3M | $-2.2M | $-694.6K | $-1.6M | $-1.3M | $-925.0K |
| Investing Activities | ||||||||
| Capital Expenditures | $0 | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $0 | — | — | — | — | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | $310.5K | $0 | — | — | — | — | — | — |
| Net Cash from Financing Activities | $5.7M | $7.8M | $10.8M | $2.3M | $709.3K | $1.4M | $1.5M | $807.1K |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | $-8.4M | — | — | — | — | — | — | — |